Bariatric surgery in inflammatory bowel disease: a comparative analysis of 450,000 patients
Surgery for Obesity and Related Diseases · 2024-11 · 20 (11) · 1119-1129
DOI: 10.1016/j.soard.2024.05.008 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Surgery for Obesity and Related Diseases, 2024-11. Verfasst von Yomna E Dean und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Alexandria University, Alexandria City, Egypt. Electronic address: yomna.mohamed1772@alexmed.edu.eg. Hauptthemen laut MEDLINE: Bariatric Surgery, Inflammatory Bowel Diseases, Obesity, Morbid, Postoperative Complications. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Studies were conducted to investigate the outcomes of bariatric surgery (BS) among inflammatory bowel disease (IBD) patients. OBJECTIVES: We aimed to analyze previous literature, comparing the outcomes of BS between IBD and non-IBD patients. SETTING: Not applicable. METHODS: PubMed, Scopus, and Web of Science were searched on 25/9/2023 for comparative studies on outcomes of BS in IBD patients. RevMan Software v5.4 was used to conduct the analysis. RESULTS: Our analysis revealed an insignificant difference in the change of body mass index (BMI) at 1-year post-BS between IBD and non-IBD patients. IBD patients had a higher risk of acute renal failure, hemorrhage, and readmission following BS (RR: 2.16, 95% CI: 1.55-3, RR: 1.57, 95% CI: 1.22-2.04, RR: 1.56, 95% CI: 1.17-2.08, respectively). No significant difference was observed between both groups regarding wounds, leak/intra-abdominal infection, thromboembolic complications, and bowel obstruction. A higher incidence of postoperative complications was seen among IBD patients undergoing RYGB compared with SG (RR: 2.21, 95% CI: 1.43-3.41). There was a significant decline in steroid use following BS in IBD patients (RR: .67, 95% CI: .53-.84). Comparison between UC and Crohn's disease (CD) revealed insignificant differences in treatment escalation or de-escalation. Both IBD and non-IBD patients had similar lengths of hospitalization. CONCLUSIONS: BS is equally effective in IBD and non-IBD patients in terms of weight loss at 1-year follow-up. Nevertheless, IBD patients are at a higher risk of postoperative complications, micronutrient deficiency, and readmission. Both UC and CD reported a decline in steroid use following surgery without a preferential advantage to a particular IBD sub-type.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Alexandria University, Alexandria City, Egypt. Electronic address: yomna.mohamed1772@alexmed.edu.eg.
- Faculty of Medicine, Alexandria University, Alexandria City, Egypt.
- Lebanese American University, Beirut, Lebanon.
- Damascus University, Damascus, Syria; Department of Cardiovascular Surgery, Mayo Clinic Health System, Eau Claire, Wisconsin.
- Faculty of Dentistry, Alexandria University, Alexandria City, Egypt.
- Faculty of Medicine, Alexandria University, Alexandria City, Egypt; Mayo Clinic, Jacksonville, Florida.
Zitieren
APA
Dean, Y. E., Mohamed, M. I., Nassar, M., Almadani, Y., Soliman, Z., Tarek, N., Zein, M., Yakout, A., Hamza, A., Elnemr, M. M., & Abdelbaki, T. N. (2024). Bariatric surgery in inflammatory bowel disease: a comparative analysis of 450,000 patients. Surgery for Obesity and Related Diseases, 20(11), 1119-1129. https://doi.org/10.1016/j.soard.2024.05.008
Vancouver
Dean YE, Mohamed MI, Nassar M, Almadani Y, Soliman Z, Tarek N, et al. Bariatric surgery in inflammatory bowel disease: a comparative analysis of 450,000 patients. Surgery for Obesity and Related Diseases. 2024;20(11):1119-1129. doi:10.1016/j.soard.2024.05.008
BibTeX
@article{Dean2024,
author = {Dean, Yomna E and Mohamed, Mohamed I and Nassar, Moussa and Almadani, Yasser and Soliman, Zakaria and Tarek, Nour and Zein, Mohamed and Yakout, Abdelrahman and Hamza, Adham and Elnemr, Mohamed M and Abdelbaki, Tamer N},
title = {Bariatric surgery in inflammatory bowel disease: a comparative analysis of 450,000 patients},
journal = {Surgery for Obesity and Related Diseases},
year = {2024},
volume = {20},
number = {11},
pages = {1119--1129},
doi = {10.1016/j.soard.2024.05.008}
}
EUVIMED